Clinical trial

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

NCT05774665

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-01-30

PhasePHASE2

Study timeline

Study start (actual)2025-01-30Date precision: day

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Treatment Resistant Depressionunresolved

Inflammationunresolved

Overweightunresolved

Interventions

Omega 3DRUG

PlaceboOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

University of Utahcollaborator

Emory Universitycollaborator

Mapped research locations

BostonMassachusetts, United States1 AtlantaGeorgia, United States1 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05774665 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.